Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections

Journal of Microbiology, Immunology and Infection

Volumn 47, Issue 3, 2014, Pages 187-196

  Huang, Sz Rung ^a   Liu, Meei Fang ^a   Lin, Chin Fu ^a   Shi, Zhi Yuan ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Carbapenem resistant; Escherichia coli; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; COLISTIN; ERTAPENEM; IMIPENEM; MEROPENEM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BROTH DILUTION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ESCHERICHIA COLI INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SURVIVAL RATE; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; TREATMENT OUTCOME;

EID: 84901586438     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.08.029     Document Type: Article

References (38)

1. Hoban D., Nicolle L., Hawser S., Bouchillon S., Badal R. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010. Diagn Microbiol Infect Dis 2011, 70:507-511.
2. Marchaim D., Chopra T., Bogan C., Bheemreddy S., Sengstock D., Jagarlamudi R., et al. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infec Contro 2012, 40:760-765.
3. Pasteran F., Mendez T., Guerriero L., Rapoport M., Corso A. Sensitive screening tests for suspected class a carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 2009, 47:1631-1639.
4. Crowley B., Benedí V.J., Doménech-Sánchez A. Expression of SHV-2 β-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems. Antimicrob Agents Chemother 2002, 46:3679-3682.
5. Doumith M., Ellington M.J., Livermore D.M., Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009, 63:659-667.
6. Lartigue M.-R., Poirel L., Poyart C., Réglier-Poupet H., Nordmann P. Ertapenem resistance of Escherichia coli. Emerg Infect Dis 2007, 13:315-317.
7. Queenan A.M., Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458.
8. KPC-2 gene. Emerg Infect Dis 2010, 16:1349-1356.
9. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17:1791-1798.
10. Poirel L., Hombrouk-Alet C., Freneaux C., Bernabeu S., Nordmann P. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010, 10:832.
11. Qi Y., Wei Z., Ji S., Du X., Shen P., Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011, 66:307-312.
12. Carrër A., Poirel L., Yilmaz M., Akan O.A., Feriha C., Cuzon G. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother 2010, 54:1369-1373.
13. Yan J.J., Wu J.J., Lee C.C., Ko W.C., Yang F.C. Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis 2010, 29:1417-1425.
14. Wu J.J., Wang L.R., Liu Y.F., Chen H.M., Yan J.J. Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital. Microb Drug Resist 2011, 17:259-266.
15. Yan J.J., Ko W.C., Chuang C.L., Wu J.J. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J Antimicrob Chemother 2002, 50:503-511.
16. Lauderdale T.L., Shi Z.Y., Lin C.F., Lai J.F., Tan M.J., Wang J.T., et al. ST11 KPC-2 Klebsiella pneumoniaedetected in Taiwan. Antimicrob Agents Chemother 2012, 56:2207-2208.
17. Chia J.H., Su L.H., Lee M.H., Kuo A.J., Shih N.Y., Siu L.K., et al. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 2010, 16:317-325.
18. Performance standards for antimicrobial susceptibility testing. 16th informational supplement. M100-S19 2009, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
19. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2006, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA. 7th ed. M7-A7.
20. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0 2012, European Committee on Antimicrobial Susceptibility Testing, EUCAST, Available at http://www.eucast.org/clinical_breakpoints/.
21. Performance standards for antimicrobial susceptibility testing. 22th Informational Supplement. M100-S22 2012, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
22. Bradford P.A., Bratu S., Urban C., Visalli M., Mariano N., Landman D., et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin Infect Dis 2004, 39:55-60.
23. Weldhagen G.F., Prinsloo A. Molecular detection of GES-2 extended spectrum β-lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa. Int J Antimicrob Agents 2004, 24:35-38.
24. Ouellette M., Bissonnette L., Roy P.H. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene. Proc Natl Acad Sci U S A 1987, 84:7378-7382.
25. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
26. Böckelmann U., Dörries H.H., Ayuso-Gabella M.N., Salgot de Marçay M., Tandoi V., Levantesi C., et al. Quantitative PCR monitoring of antibiotic resistance genes and bacterial pathogens in three European artificial groundwater recharge systems. Appl Environ Microbiol 2009, 75:154-163.
27. Cottell J.L., Webber M.A., Coldham N.G., Taylor D.L., Cerdeño-Tárraga A.M., Hauser H., et al. Complete sequence and molecular epidemiology of IncK epidemic plasmid encoding blaCTX-M-14. Emerg Infect Dis 2011, 17:645-652.
28. Shi Z.Y., Liu P.Y., Lau Y.J., Lin Y.H., Hu B.S. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis. J Clin Microbiol 1996, 34:2784-2790.
29. Oren I., Sprecher H., Finkelstein R., Hadad S., Krivoy N., Zuckerman T. Eradication of carbapenem-resistant Enterobacteriaceae colonization with non-absorbable oral antibiotic treatment. 21st ECCMID 2011, Abstract number: P693.
30. Nordmann P., Gniadkowski M., Giske C.G., Poirel L., Woodford N., Miriagou V. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012, 18:432-438.
31. Bell J.M., Chitsaz M., Turnidge J.D., Barton M., Walters L.J., Jones R.N. Prevalence and significance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol 2007, 45:1478-1482.
32. Kao C.C., Liu M.F., Lin C.F., Huang Y.C., Liu P.Y., Chang C.W., et al. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. J Microbiol Immunol Infect 2010, 43:180-187.
33. Girlich D., Poirel L., Nordmann P. Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2012, 50:477-479.
34. Carvalhaes C.G., Picão R.C., Nicoletti A.G., Xavier D.E., Gales A.C. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 2010, 65:249-251.
35. Yang S.C., Chang W.J., Chang Y.H., Tsai Y.S., Yang T.P., Juan C.W., et al. Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:601-604.
36. Livermore D.M., Warner M., Mushtaq S., Doumith M., Zhang J., Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011, 37:415-419.
37. Yang Q., Wang H., Sun H., Chen H., Xu Y., Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrob Agents Chemother 2010, 54:573-577.
38. Patel G., Huprikar S., Factor S.H., Jenkins S.G., Calfee D.P. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29:1099-1106.